Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to clarify coverage for early-onset Alzheimer’s treatments, 7-0
Summary
The Appropriations Committee voted 7-0 to do pass SB 950 to the Senate floor after authors and witnesses said the bill would align private coverage with Medicare for FDA-approved, medically necessary early-onset Alzheimer’s treatments; analysts estimated minimal near-term premium impacts.
Senator Richardson presented SB 950 on behalf of Senator Weber Pearson, saying the bill would ensure timely access to FDA-approved, medically necessary treatments for Californians with early-onset Alzheimer's disease. Richardson cited analysis from the California Health Benefits Review Program (CHBRP) estimating a premium impact of about three cents per member per month and noted…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
